Deepbridge Venture Capital

Type

Venture Capital

Status

Active

Location

Chester, United Kingdom

Total investments

84

Average round size

2M

Portfolio companies

59

Rounds per year

6.00

Lead investments

39

Follow on index

0.29

Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareWellnessManufacturingMedical DeviceMedicalLife SciencePharmaceutical

Summary

Deepbridge Capital appeared to be the VC, which was created in 2010. The leading representative office of defined VC is situated in the Chester. The fund was located in Europe if to be more exact in United Kingdom.

The fund has specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Life Science, Software. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Sky Medical Technology, PeptiGelDesign, Thalia Design Automation. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom.

The usual things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2017. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this VC is 67 percentage points more often commits exit comparing to other organizations.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Deepbridge Capital, startups are often financed by Innovate UK, SBRI Healthcare, Juno Capital Partners. The meaningful sponsors for the fund in investment in the same round are Juno Capital Partners, The North West Fund, Matt Isaacs. In the next rounds fund is usually obtained by Innovate UK, Juno Capital Partners, Matt Isaacs.

Show more

Investor highlights

Industry focus
AI/Big DataBiotech/Life SciencesClimate tech
Stage focus
SeedSeries ASeries BSeries CSeries D Show 1 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
GBR 1000000
Fund raised date
2022-02-17

Analytics

Total investments
84
Lead investments
39
Rounds per year
6.00
Follow on index
0.29
Investments by industry
  • Health Care (30)
  • Biotechnology (26)
  • Medical (23)
  • Software (19)
  • Medical Device (15)
  • Show 81 more
Investments by region
  • United Kingdom (78)
  • Australia (1)
  • United States (2)
  • Singapore (1)
  • Spain (1)
Peak activity year
2017

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
223K
Group Appearance index
0.38

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Ferryx 15 Sep 2021 Biotechnology, Pharmaceutical Seed 411K South West, Bristol, United Kingdom
Touch Biometrix 25 Apr 2022 Information Technology, Consumer, Manufacturing, Consumer Electronics Early Stage Venture Wales, St Asaph, United Kingdom
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.